05:59 AM EST, 11/04/2026 (MT Newswires) -- Sanofi (SAN.PA) is collaborating with Khalifa University of Science and Technology in the United Arab Emirates to study genetic variations linked to asthma and chronic obstructive pulmonary disease, according to a Wednesday release. Under the research agreement, the French pharmaceutical company and the university will conduct a genome-wide association study to identify genetic factors linked to the chronic respiratory diseases and better understand their biology. The study will use data from the Emirati Genome Program and Malaffi, Abu Dhabi's health information exchange platform.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.